A and B V-gene repertoires both by fluorescence-activated cell sorter (FACS) analysis with the available TCR V region-specific mAbs and by the polymerase chain reaction (PCR) with TCR V gene family-specific oligonucleotides. Among the low number of CD3 + T cells, most of the TCR V regions tested for could be detected by FACS analysis in liver, bone marrow, and spleen derived from a 14-week-old fetus and two 15-week-old fetuses. Similarly, the PCR analysis showed that the majority of the TCRAVand TCRBV families were expressed in the peripheral organs of the 13-week-old fetus, although an apparent absence of particular TCR V families was found in liver and bone marrow. This was most probably the consequence of the low number of CD3 + T cells in these organs. In 17-week-old fetal thymi the level of expression of some TCRAV and TCRBV gene families, in particular those that contain a single member, was lower compared to post-partum thymi and adult peripheral blood mononuclear cells. The combined data of FACS and PCR analysis demonstrate that TCR V genes belonging to the majority of TCR V gene families can be used in TCR o: and [~ chain rearrangements during early human fetal life. Our data also suggest that the expression levels of some of the single member TCR V gene families may be influenced by the developmental stage.
Introduction
T-lymphocytes specifically recognize processed peptide antigens, presented by major histocompatibility complex molecules, via the T-cell receptor (TCR; reviewed Correspondence to: R J. van den Elsen.
in Strominger 1989) . TCRs can be divided into two classes: the c~[3 TCR, expressed on the majority of peripheral T lymphocytes, and the 75 TCR (Brenner et al. 1986 (Brenner et al. , 1987 Strominger 1989) . Both chains of these heterodimeric TCRs are composed of variable and constant regions. Variable regions are assembled from germ-line encoded variable (V), diversity (D; only present in [3 chains), and joining (J) elements through a process called V(D)J recombination (reviewed in Schatz et al. 1992) . The currently known human TCR V elements have been grouped into 29 TCRAV families and 24 TCRBV families; the majority of these contain only a single member (Concannon et al. 1986; Kimura et al. 1987; Wilson et al. 1988; Ferradini et al. 1991; Plaza et al. 1991; Robinson 1991; Roman-Roman et al. 1991) .
Cells committed to the T-cell lineage are detectable in human fetal liver as early as the eighth week of gestation, although at this stage of fetal life rearrangement of the TCR genes is undetectable (Asma et al. 1983; Sfinchez et al. 1993) . From 12 weeks of gestation onwards the bone marrow is the primary site of lymphopoiesis (Asma et al. 1983 (Asma et al. , 1984 Gale 1987; Abe 1989 ). The thymus is colonized by (pre) T cells, generated in the hematopoietic organs at 8 or 9 weeks of gestation, and remains the major site for T-cell differentiation and selection of the TCR repertoire (Asma et al. 1983 (Asma et al. , 1984 Gale 1987; Haynes et al. 1988; Abe 1989; Sfinchez et al. 1993) . TCRA and TCRB gene rearrangements have been detected in the human fetal thymus as early as 15 weeks of gestation (Campana et al. 1989) but are likely to be initiated at an earlier stage.
Rearrangement of TCR gene elements is an ordered process. For instance, studies of mouse and human T-cell development (Born et al. 1985; Samelson et al. 1985) and analysis of human CD3-T-cell acute lymphoblastic leukemias (Furley et al. 1986; Van Dongen et al. 1987) have shown that the TCRB and TCRG loci rearrange before the TCRA and TCRD loci. Previously, we and others have demonstrated that the employment of the various TCR V gene elements in mouse and human TCR 8 chain rearrangements is under developmental control. Furthermore, the overall usage of TCRDV elements is influenced by post-thymic peripheral modification (Elliot et al. 1988; Ito et al. 1989; Lafaille et al. 1989; Krangel et al. 1990 ; Van der Stoep et al. 1990 ). The usage of TCRGV and TCRGJ gene elements was found to be tissue-specific during mouse fetal life (Lafaille et al. 1989) . Some of these observations have also been made regarding the usage pattern of TCRAJ elements during mouse development (Roth et al. 1991) .
To gain an insight into the generation of the repertoire of c~13 chain TCRs and possible developmental influences on the usage of TCR V gene families during the establishment of the human TCR A and B repertoire, we have investigated the usage of TCRAV and TCRBV families in TCR rearrangements derived from fetal liver, bone marrow, and spleen obtained at 14 (n = 1) and 15 weeks (n = 2) of gestation, using fluorescence-activated cell sorter (FACS) analysis. As the number of monoclonal antibodies specific for human TCR V-regions is limited and fetal liver and bone marrow contain extremely low numbers of T cells, we have also determined TCRAVand TCRBV gene family expression in adult peripheral blood mononuclear cells (PBMC), two human post-partum thymi, two human fetal thymi at 17 weeks of gestation, and in human fetal liver, bone marrow, spleen, gut, and cord blood at 13 weeks of gestation, using the polymerase chain reaction (PCR). 19-62772-00, Becton Dickinson) was used to separate spectrally the FITC and the PE emission. All signals were recorded as 256 channel histograms and stored into list-mode, using a consort-30 computer program (Becton Dickinson) on an HP-300 computer system (Hewlett Packard). In samples from liver and bone marrow at least 150000 nucleated cells were analyzed because of the low percentages of CD3 + ceils; for the spleen this figure was at least 50000 nucleated cells. The data obtained by using the unconjugated TCR V region-specific mAbs followed by mouse IgG subclass-specific conjugate were corrected for background staining by application of the latter antibody only.
Characterization of fetal
Optimal setting of the lymphocyte (and blast) gate for cell suspensions of the different organs was based on the fluorescence pattern obtained after staining of the cells with a cocktail of mAbs against CD45 (Becton Dickinson), CD33 (Becton Dickinson), and Glycophorin A (Immunotech).
Materials and methods
Human organs. Human fetal tissue was acquired by interruption of pregnancy on nonmedical grounds and used for the experiments after informed consent. The gestational age was determined by measurement of the foot length (Moore 1988) . As a consequence of the suction procedure we were unable to locate the thymi of the younger fetuses. The use of this material for research purposes was approved by the Ethical Research Committees of the University Hospitals of Leiden and Rotterdam under strict conditions.
To obtain fetal bone marrow, long bones were flushed with phosphate buffered saline, containing 5% bovine serum albumin (BSA) and 0.25% Na-ethylenediaminetetraacetate (EDTA) and the cells were pelleted. Bone marrow of the 11-week-old fetus was not investigated, as lymphopoiesis is marginal at this point of gestation. For PCR analysis, pelleted bone marrow and the other fetai organs were immediately frozen in liquid nitrogen and stored at -80 ° C. For FACS analysis, single-cell suspensions were prepared from liver, bone marrow, and spleen as previously described (Asma et al. 1983 (Asma et al. , 1984 . Mononuclear cells were isolated by Ficoll/ Isopaque density gradient centrifugation. Post-partum thymi were obtained from pediatric patients undergoing cardiac surgery. Adult peripheral blood was obtained by venepuncture from a healthy donor; PBMC were isolated by Ficoll/Isopaque density gradient centrifugation.
Method validation.
As the number of T cells in fetal liver and bone marrow was extremely low, we assessed whether the percentage of T cells expressing the TCRBV3 family as determined by our assay was influenced by the number of CD3 + T cells in a given sample. We therefore mixed adult PBMC with a CD3-CD10 + pre-B leukemic cell line in several ratios (100:0, 75:25, 50:50, 25:75) . The results demonstrated that, irrespective of the ratio, the percentage of TCRBV3 + T cells within the CD3 + population remained constant. Therefore, detection of this TCRBV family was not influenced by the number of CD3 + T cells present in the sample (data not shown).
RNA extraction, cDNA synthesis, PCR analysis, and Southern blotting. RNA was extracted with guanidinium salts, using standard laboratory methods (Sambrook et al. 1989 ) and dissolved into 40 ~tl of DEPC-treated water. Five ~tg of RNA was used for oligo dT-primed cDNA synthesis, using reverse transcriptase (Riboclone cDNA synthesis system; Promega, Madison, WI). Following phenol extraction, the double-stranded cDNA was dissolved in 100 ~tl TE. The expression of TCRAV and TCRBV gene families was analyzed, using PCR amplification as previously described by our laboratory (Lambert et al. 1992; Van Eggermond et al. 1993; Hawes et aL 1993; Struyk et al. 1993) , with minor modifications. Briefly, 0.5 ~tl cDNA was amplified, using 20 pmol TCRAV-and TCRBV-specific 5' sense primers, 20 pmol 3' antisense TCRAC primer or a TCRBC primer specific for both TCRBC1 and TCRBC2 loci, and 2.5 units Taq DNA polymerase (Boehringer, Mannheim, TCR message within an organ (liver, bone marrow, gut, and cord blood as opposed to thymus and spleen) varied greatly, an internal control reaction for the total amount of TCR product detected in each cDNA preparation was included in the experiments. To this end, a PCR reaction was performed, using the 3' antisense TCR C primer mentioned above and a sense primer specific for the 5' region of the constant gene element. PCR reactions were also performed without template cDNA as a negative control. In order to assess the efficiency of the TCRAV and TCRBV primers, adult PBMC were included in all experiments. The analysis of the TCRAVand TCRBVrepertoires was repeated at least three times for each organ. The possibility of maternal peripheral blood contamination was excluded by the lack of detection of IgG-encoding transcripts in RNA obtained from the fetal organs (Raaphorst et al. 1992) .
In order to maximize the chance of detecting TCR rearrangements that might be present at trace levels, the PCR reactions were performed for up to 40 cycles. The sequences of the primers have been described (Choi et aL 1989; Oksenberg et al. 1990; Lambert et al. 1992; Hawes et al. 1993; Stmyk et al. 1993 ).
Ten gl of the PCR reactions and serial dilutions (undiluted 5 times, and 25 times diluted) of the internal control amplifications were fractionated on a 1% agarose gel in 0.5 x tris-borate, blotted onto nylon membranes (Biotrace HP; Gelman Sciences, Ann Arbor, MI), and screened with 32P-labeled probes specific for the TCRAC or TCRBC region, according to protocols supplied by the manufacturer of the membranes. Autoradiography was performed using Kodak XAR films (Rochester, NY). Table 1 Figure 1 . CD3 + T cells expressing the various TCRAV and TCRBV gene elements were de-tectable in all fetal tissues analyzed but were, in contrast to spleen, present at extremely low numbers in liver and bone marrow. For instance, in the liver and bone marrow of 14-and 15-week-old fetuses, approximately 0.35% to 2.5% of the gated nucleated cells were CD3 ÷ (data not shown). Most TCRAV and TCRBV gene families tested for were expressed in these fetal organs, albeit at different levels. As shown in Table 1 , the degree of expression of these TCRAV and TCRBV gene families appeared to be subject to individual differences. This is exemplified by the expression level of the TCRAV24-TCRAV29 gene families) appeared to be expressed at a lower level in both fetal thymi.
Results

FACS analysis of TCR V gene expression in fetal liver, bone marrow, and spleen. In
PCR analysis of TCR V gene expression in fetal liver
, bone marrow, spleen, gut, and cord blood. Determination of the TCRBV repertoire in the 13-week-old fetus showed that almost all of the TCRBV families were detectable in cord blood, gut, and spleen, whereas TCRBV gene usage appeared to be restricted in liver and bone marrow (Fig. 4) . Similarly, most of the TCRAV families tested for were readily detectable in the peripheral organs of the 13-week-old fetus with the exception of the TCRAV24-TCRAV29 single-member gene families (Fig. 5) . As found in the analysis of TCRBV gene families, the level of expression of the various TCRAV gene families differed markedly in 13-week-old fetal liver and bone marrow compared to the expression of these TCRAV gene families in the periphery. In the 11-week-old fetus, the TCRBV gene family usage profiles exhibited a restricted pattern in both hematopoietic and peripheral organs which was most likely related to the low percentage of CD3 + T cells in fetal organs at this gestational age. In addition, TCRAV rearrangements were barely detectable in the investigated organs of this fetus (data not shown). 
Discussion
PCR analysis of the usage patterns of TCRAV and TCRBV families by T cells in adult PBMC and postpartum thymi indicated that all families identified to date were detectable in these tissues. In the oldest fetal samples analyzed, the 17-week-old thymi, the majority of the TCR V gene families were detectable as well, although some families appeared to be underrepresented in comparison to post-partum thymi and adult peripheral blood. This was most clearly illustrated by considering the single-member TCRAV and TCRBV gene families. The employment of the various TCRAV and TCRBV families as detected by PCR in the 13-week-old peripheral fetal tissues (gut, spleen, and cord blood) was extensive, and more diverse than the repertoire of the T ceils in the corresponding primary hematopoietic organs (liver and bone marrow).
In analogy with mouse fetal T-cell development (Roth et al. 1991 ) and human fetal B-cell development (Schroeder and Wang 1990; Raaphorst et al. 1992) , the apparent restrictions in human TCRAV and TCRBV family expression could reflect actual preferential usage of TCR V gene elements in T-cell precursors derived 1992). It is of note that TCR V gene family-specific PCR reactions were designed to detect all known members of a given family. Consequently, this may also explain why the FACS and PCR analyses were not completely overlapping, because the mAbs used are specific for a single member only.
As the peripheral fetal TCR V gene repertoire was extensive both in PCR and FACS analysis, our data show that in early human fetal TCR rearrangements V elements belonging to the majority of TCR V gene families are used by fetal T cells. Recently reported data obtained by other groups support this conclusion: studies of TCRBV expression in human fetal thymus and spleen at 15-22 weeks of gestation also demonstrated that all of the 20 tested TCRBV gene families can be used in TCR rearrangements at this stage of fetal development (Doherty et al. 1991; Bonati et al. 1992 ). In addition, transplantation of 18-to 20-week-old human fetal thymus and liver in SCID-hu mice demonstrated that all investigated TCRBVelements were expressed by the repopulating T cells (VandeKerckhove et al. 1992) . Furthermore, the relative expression levels of TCRBV elements expressed by T cells in the SCID-hu fetal thymus differed in comparison to the TCRBV usage patterns of T cells in human post-partum thymi (Doherty et al. 1991; VandeKerckhove et al. 1992) , which is compatible with our results.
Taken together, our data indicate that there are no apparent major limitations in the usage of TCRAV and TCRBV gene families in the fetal and adult tissues analyzed.
from liver and bone marrow at early fetal ages. However, considering the more diverse TCR repertoire in the periphery of these fetuses, the low number of immature and mature CD3 + T cells, especially in the hematopoietic tissues, probably lies at the heart of the apparent restricted phenotype of TCR V family usage. This was reflected by the number of cycles of PCR required to obtain a comparable level of detection in the various tissues (Figs. 2-5) . Also, FACS analysis of the expression of TCRAVand TCRBV gene products of CD3 + T-cells in 14-and 15-week-old fetal liver, bone marrow, and spleen ( Fig. 1; Table 1 ) indicated that the majority of the TCR V regions tested for were detectable, although sometimes at an extremely low level. The percentage of staining of CD3 + T cells in fetal tissue for each individual mAb was in a range similar to the staining patterns in PBMC, as previously reported by our group (Lambert et al. 1992; Hawes et al. 1993) . The mAb staining profiles suggested that the patterns of expression of TCR V families were subject to individualspecific variation, which has recently also been described in several other studies of TCR V gene expression in unrelated individuals (Akolkar et al. 1992; Robinson 1992; Rosenberg et al. 1992; Hawes et al. 1993) and T-cell subsets (Davey et al. 1991; Grunewald et al. 
